Upon HPV-16 E5 expression in both C33A cancer cell line and normal human keratinocytes, CD1d levels were downregulated via proteasomal degradation, with the inhibition of calnexin-related CD1d trafficking potentially protecting HPV-infected cells from immunological surveillance [349]. This evidence concerns the gene CD1D and cancer.